-+ 0.00%
-+ 0.00%
-+ 0.00%

GlaxoSmithKline: The AZUR-1 trial reached the primary end, achieving meaningful continuous clinical complete remission at 12 months.

智通财经·09/24/2026 12:09:06
语音播报
GlaxoSmithKline: The AZUR-1 trial reached the primary end, achieving meaningful continuous clinical complete remission at 12 months.